ğŸ§  NIZEN | Neurodegenerative Clinical Platform

NIZEN is a modular clinical monitoring platform designed for neurodegenerative diseases.

The current implementation focuses on Duchenne Muscular Dystrophy (DMD), with a scalable architecture planned to support additional conditions in future versions.

Built with Streamlit, SQLite, and Google Sheets integration, NIZEN operates in a hybrid local + cloud environment.

ğŸ¯ Vision

NIZEN aims to become a unified clinical tracking and collaboration platform for:

Duchenne Muscular Dystrophy (DMD)

ALS (planned)

SMA (planned)

Other neurodegenerative disorders (future expansion)

The system is designed to be disease-modular and extensible.

ğŸš€ Current Module: DMD
ğŸ” Secure Authentication

Role-based access (Family / Doctor / Researcher / Admin)

Password hashing (bcrypt / fallback support)

Persistent session tokens

Admin bootstrap support

ğŸ“Š Clinical Tracking

NSAA score monitoring

Weight & age tracking

Historical data logging

Timestamp-based conflict resolution

â˜ï¸ Hybrid Architecture

Local-first SQLite storage

Google Sheets cloud sync

Offline-safe sync queue

Automatic health checks

ğŸ¤– Optional AI Assistant

OpenAI API integration

Safe medical-response prompting

Escalation guidance for emergencies

ğŸ“° Research & News Feed

DMD-related RSS integration

Language filtering (TR / EN)

ğŸ—ï¸ Tech Stack

Python

Streamlit

SQLite

Pandas

streamlit-gsheets

bcrypt

ReportLab

ğŸ“‚ Project Structure
final_v50.py
/data
   â”œâ”€â”€ dmd_local.db
   â”œâ”€â”€ dmd_users.json
   â”œâ”€â”€ dmd_profiles.json
   â”œâ”€â”€ sync_queue.json
   â””â”€â”€ uploads/
âš™ï¸ Installation
pip install -r requirements.txt
streamlit run final_v50.py
ğŸ”® Roadmap

Multi-disease module architecture

Advanced analytics dashboard

Clinical report generation

Research-mode data export

Secure multi-center deployment

Regulatory compliance pathway

âš ï¸ Disclaimer

NIZEN is currently a research-oriented prototype and is not intended for certified medical deployment without regulatory approval.
